Baron Silver Stevens Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,603
Closed -$209K 107
2023
Q3
$209K Sell
3,603
-189
-5% -$11.6K 0.05% 104
2023
Q2
$242K Sell
3,792
-197
-5% -$13.2K 0.05% 97
2023
Q1
$277K Sell
3,989
-398
-9% -$28.1K 0.07% 81
2022
Q4
$316K Buy
+4,387
New +$331K 0.08% 70
2022
Q3
Sell
-4,333
Closed -$333K 105
2022
Q2
$333K Buy
4,333
+228
+6% +$17.4K 0.09% 73
2022
Q1
$299K Buy
4,105
+2
+0% +$134 0.07% 69
2021
Q4
$255K Hold
4,103
0.06% 72
2021
Q3
$242K Sell
4,103
-253
-6% -$16.7K 0.06% 66
2021
Q2
$291K Buy
4,356
+489
+13% +$31.9K 0.08% 66
2021
Q1
$244K Buy
3,867
+1,020
+36% +$63.5K 0.13% 43
2020
Q4
$176K Buy
+2,847
New +$175K 0.06% 69

Other funds holding BMY

Baron Silver Stevens Financial Advisors's BMY Position: Q4 2023 in Review

Baron Silver Stevens Financial Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,603 shares — an estimated $209K sold.

Baron Silver Stevens Financial Advisors first reported a position in BMY in Q4 2020 and held it in 11 quarters. The position peaked at $333K in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Baron Silver Stevens Financial Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Baron Silver Stevens Financial Advisors sold 3,603 Bristol-Myers Squibb shares in Q4 2023, an estimated $209K.
  • Baron Silver Stevens Financial Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 11 quarters.
  • Baron Silver Stevens Financial Advisors's Bristol-Myers Squibb position peaked at $333K in Q2 2022.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Baron Silver Stevens Financial Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.